These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 7576005

  • 1. Simultaneous increases of extracellular monoamines in microdialysates from hypothalamus of conscious rats by duloxetine, a dual serotonin and norepinephrine uptake inhibitor.
    Engleman EA, Perry KW, Mayle DA, Wong DT.
    Neuropsychopharmacology; 1995 Jul; 12(4):287-95. PubMed ID: 7576005
    [Abstract] [Full Text] [Related]

  • 2. Antagonism of serotonin 5-HT1A receptors potentiates the increases in extracellular monoamines induced by duloxetine in rat hypothalamus.
    Engleman EA, Robertson DW, Thompson DC, Perry KW, Wong DT.
    J Neurochem; 1996 Feb; 66(2):599-603. PubMed ID: 8592129
    [Abstract] [Full Text] [Related]

  • 3. Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats.
    Koch S, Hemrick-Luecke SK, Thompson LK, Evans DC, Threlkeld PG, Nelson DL, Perry KW, Bymaster FP.
    Neuropharmacology; 2003 Dec; 45(7):935-44. PubMed ID: 14573386
    [Abstract] [Full Text] [Related]

  • 4. LY248686, a new inhibitor of serotonin and norepinephrine uptake.
    Wong DT, Bymaster FP, Mayle DA, Reid LR, Krushinski JH, Robertson DW.
    Neuropsychopharmacology; 1993 Jan; 8(1):23-33. PubMed ID: 8424846
    [Abstract] [Full Text] [Related]

  • 5. Alpha2-adrenergic receptor blockade markedly potentiates duloxetine- and fluoxetine-induced increases in noradrenaline, dopamine, and serotonin levels in the frontal cortex of freely moving rats.
    Gobert A, Rivet JM, Cistarelli L, Melon C, Millan MJ.
    J Neurochem; 1997 Dec; 69(6):2616-9. PubMed ID: 9375697
    [Abstract] [Full Text] [Related]

  • 6. Blockade of the serotonin and norepinephrine uptake processes by duloxetine: in vitro and in vivo studies in the rat brain.
    Kasamo K, Blier P, De Montigny C.
    J Pharmacol Exp Ther; 1996 Apr; 277(1):278-86. PubMed ID: 8613930
    [Abstract] [Full Text] [Related]

  • 7. Brain region-specific effects of short-term treatment with duloxetine, venlafaxine, milnacipran and sertraline on monoamine metabolism in rats.
    Muneoka K, Shirayama Y, Takigawa M, Shioda S.
    Neurochem Res; 2009 Mar; 34(3):542-55. PubMed ID: 18751896
    [Abstract] [Full Text] [Related]

  • 8. Effects of duloxetine, a new serotonin and norepinephrine uptake inhibitor, on extracellular monoamine levels in rat frontal cortex.
    Kihara T, Ikeda M.
    J Pharmacol Exp Ther; 1995 Jan; 272(1):177-83. PubMed ID: 7815331
    [Abstract] [Full Text] [Related]

  • 9. Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors.
    Bymaster FP, Dreshfield-Ahmad LJ, Threlkeld PG, Shaw JL, Thompson L, Nelson DL, Hemrick-Luecke SK, Wong DT.
    Neuropsychopharmacology; 2001 Dec; 25(6):871-80. PubMed ID: 11750180
    [Abstract] [Full Text] [Related]

  • 10. Effects of the triple reuptake inhibitor amitifadine on extracellular levels of monoamines in rat brain regions and on locomotor activity.
    Golembiowska K, Kowalska M, Bymaster FP.
    Synapse; 2012 May; 66(5):435-44. PubMed ID: 22213370
    [Abstract] [Full Text] [Related]

  • 11. Effects of duloxetine, an antidepressant drug candidate, on concentrations of monoamines and their metabolites in rats and mice.
    Fuller RW, Hemrick-Luecke SK, Snoddy HD.
    J Pharmacol Exp Ther; 1994 Apr; 269(1):132-6. PubMed ID: 7513356
    [Abstract] [Full Text] [Related]

  • 12. Electrophysiological characterization of the effect of long-term duloxetine administration on the rat serotonergic and noradrenergic systems.
    Rueter LE, De Montigny C, Blier P.
    J Pharmacol Exp Ther; 1998 May; 285(2):404-12. PubMed ID: 9580577
    [Abstract] [Full Text] [Related]

  • 13. Duloxetine pharmacology: profile of a dual monoamine modulator.
    Karpa KD, Cavanaugh JE, Lakoski JM.
    CNS Drug Rev; 2002 May; 8(4):361-76. PubMed ID: 12481192
    [Abstract] [Full Text] [Related]

  • 14. Fluoxetine increases norepinephrine release in rat hypothalamus as measured by tissue levels of MHPG-SO4 and microdialysis in conscious rats.
    Perry KW, Fuller RW.
    J Neural Transm (Vienna); 1997 May; 104(8-9):953-66. PubMed ID: 9451727
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the effects of serotonin selective, norepinephrine selective, and dual serotonin and norepinephrine reuptake inhibitors on lower urinary tract function in cats.
    Katofiasc MA, Nissen J, Audia JE, Thor KB.
    Life Sci; 2002 Aug 02; 71(11):1227-36. PubMed ID: 12106588
    [Abstract] [Full Text] [Related]

  • 16. Effects of neuropeptide Y (NPY) and [D-Trp32]NPY on monoamine and metabolite levels in dialysates from rat hypothalamus during feeding behavior.
    Matos FF, Guss V, Korpinen C.
    Neuropeptides; 1996 Aug 02; 30(4):391-8. PubMed ID: 8914867
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.